BCL2 and prostate cancer: The current study reported 5-FU/rutin combination as being prone to significantly inhibit PC3 cell proliferation, inducing apoptosis via down-regulation of Bcl-2, and activating the tumor suppressor protein p53 in PC3 human prostatic cancer cells.